Section 176G:4BB - [See also Version 2 as added by a different 2016 act] Coverage for long-term antibiotic therapy for patients with Lyme disease(a) For the purposes of this section, "Long-term antibiotic therapy" and "Lyme disease" shall have the meaning ascribed to them in section 12DD of chapter 112.(b) An individual or group health maintenance contract shall provide coverage for long-term antibiotic therapy for a patient with Lyme disease when determined to be medically necessary and ordered by a licensed physician after making a thorough evaluation of the patient's symptoms, diagnostic test results or response to treatment. An experimental drug shall be covered as a long-term antibiotic therapy if it is approved for an indication by the United States Food and Drug Administration; provided, however, that a drug, including an experimental drug, shall be covered for an off-label use in the treatment of Lyme disease if the drug has been approved by the United States Food and Drug Administration.Mass. Gen. Laws ch. 176G, § 4BB
Added by Acts 2016, c. 183,§ 4, eff. 7/1/2016.